Location History:
- Tarrytown, NY (US) (2022 - 2023)
- Wilton, CT (US) (2010 - 2024)
Company Filing History:
4 out of 1,343 
1 out of 3,539 
Years Active: 2010-2024
Title: The Innovative Contributions of Lorah Perlee
Introduction
Lorah Perlee is a distinguished inventor based in Wilton, CT, known for her significant contributions to the fields of genetics and allergy treatment. With a total of five patents to her name, she has made remarkable strides in understanding and addressing complex medical conditions.
Latest Patents
Among her latest patents, one focuses on methods of associating genetic variants with clinical outcomes in patients suffering from age-related macular degeneration treated with anti-VEGF. This patent discloses methods and compositions for linking genetic variants with intraretinal fluid, as well as visual acuity, anatomic outcomes, or treatment frequency. Another notable patent involves methods of treating allergy using anti-Bet v 1 antibodies. This disclosure provides innovative approaches for treating, preventing, or ameliorating symptoms of birch allergy or allergic disease by administering antibodies that bind to Bet v 1.
Career Highlights
Lorah has worked with prominent organizations such as Regeneron Pharmaceuticals, Inc. and the National Institutes of Health, a component of the US Department of Health & Human Services. Her work in these institutions has allowed her to collaborate with leading experts in her field and contribute to groundbreaking research.
Collaborations
Throughout her career, Lorah has collaborated with notable colleagues, including Sara Hamon and Charles Paulding. These partnerships have further enhanced her research and innovation efforts.
Conclusion
Lorah Perlee's innovative work in genetics and allergy treatment exemplifies her dedication to advancing medical science. Her patents reflect her commitment to improving patient outcomes and addressing critical health challenges.